Product Image

Calcium Bone Maker Complex with MCH-Cal and VitaMK7

Doctor's Best
4.7
★ ★ ★ ★ ★
(7356 ratings)
Calcium 300 mg
Boron 2 mg
Copper 0.6 mg
Product Image
Score83
A well-designed MCH-Cal bone formula with D3, MK-7, magnesium malate, and boron. Zinc dose ambiguity and six capsules are the clearest drawbacks.
How scoring works
Quantity:180 Capsule(s) • (60 servings)
Goals:
Bone Health

Score 83

A well-designed MCH-Cal bone formula with D3, MK-7, magnesium malate, and boron. Zinc dose ambiguity and six capsules are the clearest drawbacks.
How scoring works
$18.08($0.30 per serving)
Walmart
$ 18.99
iHerb
$ 18.99
Amazon
$ 18.99
Pure Formulas
$ 18.08
Vitacost
$ 18.99
Report prices

Analysis

The formula combines MCH-Cal calcium and phosphorus with dimagnesium malate, vitamin D3, MK-7, boron, copper, manganese, potassium, and vitamin C. This is a coherent set of bone-mineral nutrients with several useful forms.

The bovine bone extract provides a natural mineral matrix, but its large entry can be confusing beside the elemental calcium amount. Zinc is listed without a usable unit, preventing assessment of its actual dose.

Six capsules per serving create a substantial pill burden despite strong formulation logic. The product best fits adults who specifically want MCH-Cal and can safely use vitamin K2.

Who is it for
  • Adults seeking a comprehensive bone formula
  • People interested in MCH-Cal bovine bone matrix
  • Users comfortable taking six capsules
Best for
  • Bone-mineral support
  • Combining calcium with D3 and MK-7
  • Magnesium malate and boron intake

Pros

  • Uses MCH-Cal calcium and phosphorus
  • Provides vitamin D3 and MK-7 K2
  • Includes dimagnesium malate and boron
  • Adds copper, manganese, and potassium
  • Coherent bone-focused design

Cons

  • Requires six capsules
  • Zinc amount lacks a usable unit
  • Bovine source is unsuitable for vegans
  • Label structure creates dose ambiguity

Warnings

  • Vitamin K2 can interfere with warfarin-type anticoagulants and requires stable clinician-guided intake.
  • Calcium and magnesium can reduce absorption of levothyroxine, bisphosphonates, and tetracycline-class antibiotics when taken together, so doses need separation.
  • People with kidney disease should not use multi-mineral calcium products without clinical supervision.
  • The bovine bone source is unsuitable for people who avoid bovine-derived ingredients.

Nutrient quality

93 Highest impact

Hydroxyapatite calcium, MK-7, magnesium malate, zinc monomethionine, and citrate minerals are well-regarded forms. Calcium, magnesium, vitamin D3, MK-7, and boron provide complementary useful amounts.

.

Ingredient transparency

78 High impact

Most active amounts are clear, but the zinc entry uses an unexplained unit. The supplied data does not include a complete capsule and inactive ingredient list.

.

Customer satisfaction

73 High impact

The aggregate satisfaction measure and review volume support a favorable first impression. Missing firsthand feedback leaves repeat complaints and real-world purpose fit uncertain.

.

Value for money

86 Highest impact

The moderate product cost is justified by premium forms and strong bone-focused coherence. Each serving provides good value across several complementary bone actives.

.
Report analysis

Goals

Bone Health
Impact
Highest effect
A+ Goal FitA- Strength of SupportA CoverageA+ Formula Quality
Vitamin K · 40 mcgMagnesium · 150 mgCalcium · 1363 mgVitamin D · 23 mcgCopper · 0.6 mgManganese · 1 mgBoron · 2 mgZinc · 6 NPVitamin C · 125 mg

The formula directly targets mineral structure, absorption, and remodeling with multiple bone-specific actives. Hydroxyapatite calcium, vitamin D, vitamin K, magnesium, and boron have strong complementary skeletal rationale.

The formula provides useful amounts across calcium, magnesium, vitamin D, K2, boron, and phosphorus. The formula covers mineral structure, absorption, remodeling, and trace-mineral support.

Study evidence
Boron Supportive 5 studies
Calcium Supportive 144 studies
Magnesium Supportive 48 studies
Vitamin D Supportive 202 studies
Vitamin K Supportive 78 studies

Ingredients

IngredientAmount per serving
Vitamin C (Ascorbic Acid)
125 mg
Vitamin D3 (Cholecalciferol)
23 mcg
Vitamin K2 (Menaquinone-7)
40 mcg
Calcium (MCH-Cal)
300 mg
Phosphorus (MCH-Cal)
123 mg
Magnesium (DiMagnesium Malate)
150 mg
Zinc (Zinc Monomethionine)
6 NP
Copper (Copper Gluconate)
0.6 mg
Manganese (Manganese Citrate)
1 mg
Potassium (Potassium Citrate)
49 mg
MCH-Cal (Bovine Bone Extract)
1363 mg
Boron (Boron Citrate)
2 mg
Gluten Free Adults 18–50
Report overview
Calcium (MCH-Cal) · 300 mg OverallScore93
A+ Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyA+ Value

MCH-Cal supplies calcium in a bone-derived hydroxyapatite form with strong absorption potential and clear elemental disclosure. The serving amount is useful for general supplementation, while vitamin D3 and vitamin K2 add relevant bone-support cofactors. Vitamin K2 may interfere with warfarin and similar vitamin K antagonist medicines, so users of these drugs need clinician-guided intake.

Boron (Boron Citrate) · 2 mg OverallScore58
C Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyF Value

Boron citrate offers a well-absorbed organic form within a broad bone-support formula. The 2 mg serving is suitable for maintenance but sits below the preferred target range for a dedicated boron supplement. Cost efficiency is limited for boron alone, while the three-capsule serving also reduces convenience.

C- Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyB+ Value

Copper gluconate is clearly disclosed but is a basic organic salt rather than a premium chelate. The 0.6 mg serving falls below the adult daily target and may be too small for targeted supplementation; the zinc amount lacks a clear unit, so the zinc-to-copper balance cannot be confirmed. Serving cost is close to the collection benchmark, with broader nutrient coverage adding value.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Associations of dietary calcium intake with metabolic syndrome and bone mineral density among the Korean population: KNHANES 2008-2011.
    Kim MK; Chon SJ; Noe EB; Roh YH; Yun BH; Cho S; Choi YS; Lee BS; Seo SK · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018
    Cross-sectional study14,705 participantsBone Health forCalcium
  2. Calcium supplementation during pregnancy and maternal and offspring bone health: a systematic review and meta-analysis.
    Tihtonen K; Korhonen P; Isojärvi J; Ojala R; Ashorn U; Ashorn P; Tammela O · Annals of the New York Academy of Sciences · 2022
    Meta-analysis1,566 participants7 studies pooledBone Health forCalcium
  3. Bone turnover and the response to alendronate treatment in postmenopausal osteoporosis.
    Gonnelli S; Cepollaro C; Pondrelli C; Martini S; Montagnani A; Monaco R; Gennari C · Calcified tissue international · 1999
    Randomized trial100 participantsBone Health forCalcium
  4. [Comparative study of the urinary excretion of boron, calcium, magnesium and phosphorus in postmenopausal women with and without osteoporosis].
    José Ramón V; Mora Mora M; Marino Alarcón O; Hernández G; Josefina Linares L; Urdaneta Romero H; Arévalo González E · Investigacion clinica · 2013
    Case-control study45 participantsBone Health forBoron
  5. Effects of boron supplementation on bone mineral density and dietary, blood, and urinary calcium, phosphorus, magnesium, and boron in female athletes.
    Meacham SL; Taper LJ; Volpe SL · Environmental health perspectives · 1995
    Randomized trial28 participantsBone Health forBoron
  6. Effect of dietary boron on mineral, estrogen, and testosterone metabolism in postmenopausal women.
    Nielsen FH; Hunt CD; Mullen LM; Hunt JR · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 1987
    Single-arm trial12 participantsBone Health forBoron
  7. The relationship between boron and magnesium status and bone mineral density in the human: a review.
    Volpe SL; Taper LJ; Meacham S · Magnesium research · 1994
    Narrative reviewBone Health forBoron
  8. Metabolic responses of postmenopausal women to supplemental dietary boron and aluminum during usual and low magnesium intake: boron, calcium, and magnesium absorption and retention and blood mineral concentrations
    C D Hunt, J L Herbel, F H Nielsen · The American Journal of Clinical Nutrition · 1997
    Non-randomized trial11 participantsBone Health forBoron
  9. What is the impact of daily oral supplementation of vitamin D3 (cholecalciferol) plus calcium on the incidence of hip fracture in older people? A systematic review and meta-analysis.
    Manoj P; Derwin R; George S · International journal of older people nursing · 2023
    Meta-analysis12,620 participants7 studies pooledBone Health forCalcium
  10. Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial.
    Storm D; Eslin R; Porter ES; Musgrave K; Vereault D; Patton C; Kessenich C; Mohan S; Chen T; Holick MF; Rosen CJ · The Journal of clinical endocrinology and metabolism · 1998
    Randomized trial60 participantsBone Health forCalcium
  11. The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women.
    Prince R; Devine A; Dick I; Criddle A; Kerr D; Kent N; Price R; Randell A · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 1995
    Randomized trial168 participantsBone Health forCalcium
  12. The efficacy of calcium supplementation alone in elderly Thai women over a 2-year period: a randomized controlled trial.
    Rajatanavin R; Chailurkit L; Saetung S; Thakkinstian A; Nimitphong H · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Randomized trial404 participantsBone Health forCalcium
  13. Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial.
    Bonjour JP; Carrie AL; Ferrari S; Clavien H; Slosman D; Theintz G; Rizzoli R · The Journal of clinical investigation · 1997
    Randomized trial149 participantsBone Health forCalcium
  14. Association between Serum Magnesium and Fractures: A Systematic Review and Meta-Analysis of Observational Studies.
    Dominguez LJ; Veronese N; Ciriminna S; Pérez-Albela JL; Vásquez-López VF; Rodas-Regalado S; Di Bella G; Parisi A; Tagliaferri F; Barbagallo M · Nutrients · 2023
    Meta-analysis119,755 participants4 studies pooledBone Health forMagnesium
  15. Bioabsorbable Magnesium-Based Materials Potential and Safety in Bone Surgery: A Systematic Review.
    Hung CH; Kwok YC; Yip J; Wong HH; Leung YY · Craniomaxillofacial trauma & reconstruction · 2025
    Systematic review386 participants8 studies pooledBone Health forMagnesium
  16. Vascularized bone grafting fixed by biodegradable magnesium screw for treating osteonecrosis of the femoral head.
    Zhao D; Huang S; Lu F; Wang B; Yang L; Qin L; Yang K; Li Y; Li W; Wang W; Tian S; Zhang X; Gao W; Wang Z; Zhang Y; Xie X; Wang J; Li J · Biomaterials · 2016
    Randomized trial48 participantsBone Health forMagnesium
  17. An update on magnesium and bone health.
    Rondanelli M; Faliva MA; Tartara A; Gasparri C; Perna S; Infantino V; Riva A; Petrangolini G; Peroni G · Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2022
    Narrative reviewBone Health forMagnesium
  18. Sex-specific differences in the association of magnesium intake with femoral neck bone mineral density among older adults.
    Wang B; Tan X; Yao X; Zhu Z · Endocrine connections · 2025
    Cross-sectional study1,343 participantsBone Health forMagnesium
  19. Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial.
    Moon RJ; D' Angelo S; Curtis EM; Ward KA; Crozier SR; Schoenmakers I; Javaid MK; Bishop NJ; Godfrey KM; Cooper C; Harvey NC; MAVIDOS Trial Group · The American journal of clinical nutrition · 2024
    Randomized trial454 participantsBone Health forVitamin D
  20. Vitamin D analogs and bone: preclinical and clinical studies with eldecalcitol.
    Matsumoto T; Takano T; Saito H; Takahashi F · BoneKEy reports · 2014
    Narrative reviewBone Health forVitamin D
  21. Efficacy of vitamin D fortified foods on bone mineral density and serum bone biomarkers: A systematic review and meta-analysis of interventional studies.
    Tangestani H; Djafarian K; Emamat H; Arabzadegan N; Shab-Bidar S · Critical reviews in food science and nutrition · 2020
    Meta-analysis1,786 participants20 studies pooledBone Health forVitamin D
  22. Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial.
    Tsujita M; Doi Y; Obi Y; Hamano T; Tomosugi T; Futamura K; Okada M; Hiramitsu T; Goto N; Isaka Y; Takeda A; Narumi S; Watarai Y · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Randomized trial193 participantsBone Health forVitamin D
  23. Vitamin D supplementation and bone health in post-menopausal women: a 24-month randomized controlled intervention with enhanced bioavailability formulations.
    Rasool N; Munir Y · European journal of clinical nutrition · 2026
    Randomized trial612 participantsBone Health forVitamin D
  24. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
    Cockayne S; Adamson J; Lanham-New S; Shearer MJ; Gilbody S; Torgerson DJ · Archives of internal medicine · 2006
    Meta-analysis13 studies pooledBone Health forVitamin K
  25. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Randomized trial244 participantsBone Health forVitamin K
  26. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S · Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2001
    Randomized trial92 participantsBone Health forVitamin K
  27. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
    Zhou M; Han S; Zhang W; Wu D · Journal of bone and mineral metabolism · 2022
    Meta-analysis6,853 participants9 studies pooledBone Health forVitamin K
  28. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
    Koitaya N; Sekiguchi M; Tousen Y; Nishide Y; Morita A; Yamauchi J; Gando Y; Miyachi M; Aoki M; Komatsu M; Watanabe F; Morishita K; Ishimi Y · Journal of bone and mineral metabolism · 2015
    Randomized trial48 participantsBone Health forVitamin K